Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004961956 | SCV005475125 | uncertain significance | Inborn genetic diseases | 2024-09-27 | criteria provided, single submitter | clinical testing | The c.2212C>A (p.P738T) alteration is located in exon 11 (coding exon 11) of the PKD1 gene. This alteration results from a C to A substitution at nucleotide position 2212, causing the proline (P) at amino acid position 738 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005006591 | SCV005643143 | uncertain significance | Polycystic kidney disease, adult type | 2024-06-13 | criteria provided, single submitter | clinical testing |